HBIO Annual Total Long Term Liabilities
$37.75 M
-$12.14 M-24.34%
31 December 2023
Summary:
As of January 23, 2025, HBIO annual total long term liabilities is $37.75 million, with the most recent change of -$12.14 million (-24.34%) on December 31, 2023. During the last 3 years, it has fallen by -$20.77 million (-35.49%). HBIO annual total long term liabilities is now -37.50% below its all-time high of $60.40 million, reached on December 31, 2018.HBIO Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HBIO Quarterly Long Term Liabilities
$43.17 M
+$4.12 M+10.56%
30 September 2024
Summary:
As of January 23, 2025, HBIO quarterly total long term liabilities is $43.17 million, with the most recent change of +$4.12 million (+10.56%) on September 30, 2024. Over the past year, it has increased by +$1.92 million (+4.66%). HBIO quarterly long term liabilities is now -37.77% below its all-time high of $69.37 million, reached on March 31, 2018.HBIO Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HBIO Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -24.3% | +4.7% |
| 3 y3 years | -35.5% | -19.3% |
| 5 y5 years | -37.5% | -32.5% |
HBIO Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -29.6% | at low | -20.7% | +14.3% |
| 5 y | 5-year | -35.5% | at low | -26.2% | +14.3% |
| alltime | all time | -37.5% | >+9999.0% | -37.8% | >+9999.0% |
Harvard Bioscience Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $43.17 M(+10.6%) |
| June 2024 | - | $39.04 M(+1.0%) |
| Mar 2024 | - | $38.67 M(+2.4%) |
| Dec 2023 | $37.75 M(-24.3%) | $37.75 M(-8.5%) |
| Sept 2023 | - | $41.24 M(-7.5%) |
| June 2023 | - | $44.57 M(-7.2%) |
| Mar 2023 | - | $48.02 M(-3.7%) |
| Dec 2022 | $49.89 M(-7.0%) | $49.89 M(-7.0%) |
| Sept 2022 | - | $53.67 M(-1.4%) |
| June 2022 | - | $54.41 M(-0.1%) |
| Mar 2022 | - | $54.44 M(+1.5%) |
| Dec 2021 | $53.63 M(-8.4%) | $53.63 M(+0.3%) |
| Sept 2021 | - | $53.48 M(+2.8%) |
| June 2021 | - | $52.00 M(-2.6%) |
| Mar 2021 | - | $53.42 M(-8.7%) |
| Dec 2020 | $58.52 M(+1.1%) | $58.52 M(+14.3%) |
| Sept 2020 | - | $51.20 M(-1.5%) |
| June 2020 | - | $51.95 M(-8.5%) |
| Mar 2020 | - | $56.78 M(-1.9%) |
| Dec 2019 | $57.86 M(-4.2%) | $57.86 M(-9.6%) |
| Sept 2019 | - | $63.98 M(-1.6%) |
| June 2019 | - | $65.05 M(-2.7%) |
| Mar 2019 | - | $66.85 M(+10.7%) |
| Dec 2018 | $60.40 M(+319.1%) | $60.40 M(-6.8%) |
| Sept 2018 | - | $64.82 M(-1.6%) |
| June 2018 | - | $65.84 M(-5.1%) |
| Mar 2018 | - | $69.37 M(+381.3%) |
| Dec 2017 | $14.41 M(-31.3%) | $14.41 M(-27.3%) |
| Sept 2017 | - | $19.83 M(-2.9%) |
| June 2017 | - | $20.41 M(-1.1%) |
| Mar 2017 | - | $20.63 M(-1.6%) |
| Dec 2016 | $20.97 M(-9.3%) | $20.97 M(-4.0%) |
| Sept 2016 | - | $21.84 M(-3.2%) |
| June 2016 | - | $22.57 M(-5.1%) |
| Mar 2016 | - | $23.79 M(+2.9%) |
| Dec 2015 | $23.13 M(+3.5%) | $23.13 M(+5.1%) |
| Sept 2015 | - | $22.00 M(-2.4%) |
| June 2015 | - | $22.53 M(-5.6%) |
| Mar 2015 | - | $23.86 M(+6.7%) |
| Dec 2014 | $22.35 M(-10.2%) | $22.35 M(-5.8%) |
| Sept 2014 | - | $23.72 M(+2.6%) |
| June 2014 | - | $23.12 M(-2.2%) |
| Mar 2014 | - | $23.63 M(-5.1%) |
| Dec 2013 | $24.89 M(+28.5%) | $24.89 M(-7.8%) |
| Sept 2013 | - | $27.01 M(-1.4%) |
| June 2013 | - | $27.38 M(+52.6%) |
| Mar 2013 | - | $17.94 M(-7.4%) |
| Dec 2012 | $19.37 M | $19.37 M(-6.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2012 | - | $20.69 M(-4.2%) |
| June 2012 | - | $21.60 M(-4.7%) |
| Mar 2012 | - | $22.67 M(+5.1%) |
| Dec 2011 | $21.58 M(-7.2%) | $21.58 M(+3.9%) |
| Sept 2011 | - | $20.78 M(-4.9%) |
| June 2011 | - | $21.86 M(-2.7%) |
| Mar 2011 | - | $22.46 M(-3.4%) |
| Dec 2010 | $23.25 M(+17.9%) | $23.25 M(+5.2%) |
| Sept 2010 | - | $22.11 M(+28.2%) |
| June 2010 | - | $17.24 M(-3.8%) |
| Mar 2010 | - | $17.92 M(-9.1%) |
| Dec 2009 | $19.72 M(+490.7%) | $19.72 M(+58.6%) |
| Sept 2009 | - | $12.43 M(+260.1%) |
| June 2009 | - | $3.45 M(+9.7%) |
| Mar 2009 | - | $3.15 M(-5.8%) |
| Dec 2008 | $3.34 M(-60.1%) | $3.34 M(+32.3%) |
| Sept 2008 | - | $2.52 M(-11.2%) |
| June 2008 | - | $2.84 M(-0.3%) |
| Mar 2008 | - | $2.85 M(-66.0%) |
| Dec 2007 | $8.38 M(+25.7%) | $8.38 M(+28.1%) |
| Sept 2007 | - | $6.54 M(+68.2%) |
| June 2007 | - | $3.89 M(-24.4%) |
| Mar 2007 | - | $5.14 M(-22.8%) |
| Dec 2006 | $6.66 M(-34.8%) | $6.66 M(+200.3%) |
| Sept 2006 | - | $2.22 M(-0.9%) |
| June 2006 | - | $2.24 M(+5.9%) |
| Mar 2006 | - | $2.11 M(-79.3%) |
| Dec 2005 | $10.22 M(-47.5%) | $10.22 M(-34.8%) |
| Sept 2005 | - | $15.69 M(-6.2%) |
| June 2005 | - | $16.72 M(-5.8%) |
| Mar 2005 | - | $17.76 M(-8.7%) |
| Dec 2004 | $19.46 M(+39.5%) | $19.46 M(-1.8%) |
| Sept 2004 | - | $19.82 M(+2.4%) |
| June 2004 | - | $19.36 M(-6.0%) |
| Mar 2004 | - | $20.59 M(+47.6%) |
| Dec 2003 | $13.95 M(+435.9%) | $13.95 M(+475.9%) |
| Sept 2003 | - | $2.42 M(+4.0%) |
| June 2003 | - | $2.33 M(-7.0%) |
| Mar 2003 | - | $2.50 M(-3.8%) |
| Dec 2002 | $2.60 M(-23.3%) | $2.60 M(-7.8%) |
| Sept 2002 | - | $2.83 M(-0.6%) |
| June 2002 | - | $2.84 M(-13.6%) |
| Mar 2002 | - | $3.29 M(-3.1%) |
| Dec 2001 | $3.39 M(+3098.9%) | $3.39 M(+2256.9%) |
| Sept 2001 | - | $144.00 K(-0.7%) |
| June 2001 | - | $145.00 K(+38.1%) |
| Mar 2001 | - | $105.00 K(-1.0%) |
| Dec 2000 | $106.10 K(-97.9%) | $106.10 K |
| Dec 1999 | $5.12 M | - |
FAQ
- What is Harvard Bioscience annual total long term liabilities?
- What is the all time high annual total long term liabilities for Harvard Bioscience?
- What is Harvard Bioscience annual total long term liabilities year-on-year change?
- What is Harvard Bioscience quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Harvard Bioscience?
- What is Harvard Bioscience quarterly long term liabilities year-on-year change?
What is Harvard Bioscience annual total long term liabilities?
The current annual total long term liabilities of HBIO is $37.75 M
What is the all time high annual total long term liabilities for Harvard Bioscience?
Harvard Bioscience all-time high annual total long term liabilities is $60.40 M
What is Harvard Bioscience annual total long term liabilities year-on-year change?
Over the past year, HBIO annual total long term liabilities has changed by -$12.14 M (-24.34%)
What is Harvard Bioscience quarterly total long term liabilities?
The current quarterly long term liabilities of HBIO is $43.17 M
What is the all time high quarterly long term liabilities for Harvard Bioscience?
Harvard Bioscience all-time high quarterly total long term liabilities is $69.37 M
What is Harvard Bioscience quarterly long term liabilities year-on-year change?
Over the past year, HBIO quarterly total long term liabilities has changed by +$1.92 M (+4.66%)